Intravenous Steroid-Refractory Ulcerative Colitis
1 clinical trials · Condition
◉ Watch Intravenous Steroid-Refractory Ulcerative Colitis
| Record | Firm | Date |
|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (NCT00502294) | Facet Biotech |
Track Intravenous Steroid-Refractory Ulcerative Colitis automatically
Every clearance here is in the API, with alerts when new ones post.